Background: Atherosclerotic cardiovascular disease, a major contributor to healthcare expenditures, is the leading complication in adults with diabetes mellitus. Composite risk factor control, defined...
Glycosylation is a key structural modification of immunoglobulin G (IgG) that modulates its effector functions and has multiple roles in balancing inflammation. Altered IgG glycosylation has been repo...
Background Cardiovascular disorders are the leading global cause of death, with more premature mortality in middle-income countries (MICs) than in high-income countries (HICs), challenging health syst...
Background Sarcopenia is a global challenge and a potential modifiable risk factor for cardiorenal diseases. However, the geospatial variation of sarcopenia in China and its region-specific associatio...
COVID-19 has accelerated the challenges of cardiovascular complications among patients, leading to the increased urgency of safe, trustworthy, and smart healthcare information management systems. Elec...
Background The recent definition of pulmonary hypertension (PH) has expanded the category of combined pre- and post-capillary (CPC) PH. Its impact on PH prevalence and prognosis in advanced heart fail...
Background: Community-acquired pneumonia is an established independent risk factor for atherosclerosis, yet the molecular mechanisms translating acute pulmonary infection into chronic vascular patholo...
Background Hypertension is a leading modifiable cause of cardiovascular mortality globally. Nationally representative data on the full hypertension care cascade prevalence, awareness, treatment, and b...
SinoXiv